Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Pilot study of I-131-tositumomab in advanced, previously treated, refractory chronic lymphocytic leukemia. Palestro, C. J., Gupta, N. K., Cao, T. M., French, J. N., Goris, M. L., Capizi, R., Califano, J., Rai, K. R., Coutre, S. E. SOC NUCLEAR MEDICINE INC. 2002: 312P–312P
View details for Web of Science ID 000175560801166